Thomas M. Habermann Lab

The Thomas M. Habermann Lab focuses on cancer research, particularly hematologic malignancies like multiple myeloma and lymphoma. The lab aims to understand the underlying mechanisms of these diseases, develop new treatment strategies, and improve patient outcomes. Researchers use advanced techniques in molecular biology and genetic analysis to study how cancer cells grow and respond to therapies. By exploring these processes, the lab contributes to the development of targeted therapies that can more effectively treat patients with blood cancers, ultimately striving for breakthroughs in cancer management and patient care.